Rhinoscleroma laboratory findings

Revision as of 01:27, 6 December 2012 by Prashanthsaddala (talk | contribs)
Jump to navigation Jump to search

Rhinoscleroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Rhinoscleroma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rhinoscleroma laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rhinoscleroma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rhinoscleroma laboratory findings

CDC on Rhinoscleroma laboratory findings

Rhinoscleroma laboratory findings in the news

Blogs on Rhinoscleroma laboratory findings

Directions to Hospitals Treating Rhinoscleroma

Risk calculators and risk factors for Rhinoscleroma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

Micrograph showing abundant subepithelial histiocytes in a case of rhinoscleroma. H&E stain.

A positive culture in MacConkey agar is diagnostic, but cultures are only positive in 50-60% of cases. Diagnostic characteristics are most commonly found in the granulomatous stage and are described as being chronic inflammatory cells, Russell bodies, and pseudoepitheliomatous hyperplasia, and groups of large vacuolated histiocytes containing Klebsiella rhinoscleromatis (Mikulicz cells).

References

Template:WH Template:WS